Bristol NHS Group, in partnership with Highland, has successfully hosted its first Local Health Tech Showcase, bringing health and social care staff from across Bristol, North Somerset and South Gloucestershire (BNSSG) together with leading technology suppliers to explore how digital innovation can support frontline services and improve patient care.
Held at BAWA Health & Leisure, the event welcomed more than 250 attendees, who engaged directly with 40 exhibitors, showcasing a wide range of digital and physical solutions designed to address the real-world challenges faced by the NHS and its workforce.
As such, it offers the potential to shift an all too common late stage, terminal disease diagnosis to one that is at an early stage (stage 0) and treatable, say the researchers.
In a new study, Duke Health researchers found that artificial intelligence tools can analyze routine electronic health records to accurately estimate a child’s risk of developing ADHD years before a typical diagnosis.
The study examines how Clinical Decision Support Systems (CDSS) can transform cardiovascular disease management - a leading cause of death in Australia - by providing more accurate, timely decisions while addressing real-world barriers like workflow integration, usability and clinician adoption.
The discovery is a demonstration of how AI could dramatically improve the slow and costly search for new antimicrobial medicines, as bacteria and other microbes continue to evolve resistance to our current suite of drugs.
Survival analysis is central to clinical oncology. Modern cancer studies can now measure gene activity in single cells from a patient’s tumor and link this information to how long patients live.
UVA’s Nikolay V. Dokholyan, PhD, and colleagues have developed a suite of artificial intelligence-powered tools, called YuelDesign, YuelPocket and YuelBond, that work together to transform how new drugs are created.